MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Pathophysiology"

  • 2019 International Congress

    Abnormal metabolic brain network in multiple system atrophy and progressive supranuclear palsy: a replication on a new European cohort

    T. Rus, E. Rebec, P. Tomše, A. Studen, M. Grmek, C. Tang, D. Eidelberg, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify characteristic metabolic brain patterns specific for multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a new cohort of patients and…
  • 2019 International Congress

    Increased lysosphingolipids levels in blood of patients with multiple system atrophy

    K. Senkevich, G. Baydakova, A. Emelyanov, M. Nikolaev, A. Kopytova, I. Miliukhina, E. Gracheva, A. Kudrevatykh, I. Krasakov, L. Khublarova, I. Fursova, Y. Irishina, N. Zalutskaya, Y. Beltseva, E. Zakharova, S. Pchelina (Saint-Petersburg, Russian Federation)

    Objective: To estimate activity of lysosomal enzymes and lysosphingolipids concentration in dry blood spot of patients with synuleinopathies: Parkinson’s disease (PD), dementia with Lewy bodies…
  • 2019 International Congress

    Hypothalamic functional connectivity correlates with autonomic symptom burden in patients with Multiple System Atrophy

    M. Sklerov, N. Browner, D. Drazheva, E. Dayan (Chapel Hill, NC, USA)

    Objective: To investigate the association between autonomic symptom burden and hypothalamic functional connectivity in patients with MSA. Background: Multiple system atrophy (MSA) is a progressive…
  • 2019 International Congress

    Pain in patients with multiple system atrophy: a pain-related evoked potential study

    M. Takeda, F. Okada, H. Tachibana, S. Kasama, H. Yoshikawa (Nishinomiya, Japan)

    Objective: The purpose of this study was to investigate the pathophysiology of pain in patients with multiple system atrophy (MSA). Background: MSA is an atypical…
  • 2018 International Congress

    Broad White Matter Impairment in Multiple System Atrophy: A case for Oligodendrocyte Dysfunction

    N. del Campo, O. Phillips, F. Ory-Magne, M. Galitzky, C. Brefel-Coubron, C. Thalamas, K. Narr, S. Joshi, M. Singh, P. Péran, A. Pavy-LeTraon, O. Rascol (Toulouse, France)

    Objective: The main objective of this study was to investigate if there are widespread white matter abnormalities in multiple system atrophy (MSA). Background: MSA differs…
  • 2018 International Congress

    Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

    P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)

    Objective: Using multimodal MRI, the aim of the study was to evaluate brain changes due to disease progression in multiple system atrophy (MSA) patients. Background:…
  • 2018 International Congress

    Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

    N. Lev, Y. Barhum (Kfar Saba, Israel)

    Objective: The aim of this study was to examine the effect of mannitol treatment in a mice model of MSA. Background: Alpha-synuclein aggregation represents the…
  • 2018 International Congress

    Serum cholesterol level is associated with risk of MSA

    YC. Lu, MC. Kuo, RM. Wu (Taipei, Taiwan)

    Objective: We aim to ascertain the association between serum cholesterol and multiple system atrophy (MSA). Background: MSA, a common form of atypical parkinsonism, is a…
  • 2018 International Congress

    Peripheral immune activation was associated with multiple system atrophy

    B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)

    Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…
  • 2018 International Congress

    Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

    T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)

    Objective: To estimate the levels of serum uric acid in Idiopathic Parkinson’s disease (IPD) and various Parkinson plus syndromes (PPS). To correlate the uric acid…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley